POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Clinical trials for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo approach tested in kids with tough cancers
Disease control CompletedThis early-phase study tested the safety of a modified chemotherapy regimen, called dose-adjusted EPOCH-R, in children with aggressive B-cell cancers like diffuse large B-cell lymphoma. The treatment involved giving some drugs as a continuous infusion over four days and adjusting…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Virus tracking study aims to protect transplant patients from cancer risk
Knowledge-focused CompletedThis study followed 509 kidney transplant patients to understand how monitoring Epstein-Barr virus (EBV) levels might help predict serious risks. Researchers tracked patients' blood for persistent EBV infection to see if it signaled a higher chance of developing certain cancers, …
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC